Form 8-K - Current report:
SEC Accession No. 0000950170-22-014944
Filing Date
2022-08-05
Accepted
2022-08-05 07:10:10
Documents
12
Period of Report
2022-08-05
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20220805.htm   iXBRL 8-K 49874
  Complete submission text file 0000950170-22-014944.txt   169380

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20220805.xsd EX-101.SCH 2454
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20220805_lab.xml EX-101.LAB 13896
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20220805_pre.xml EX-101.PRE 10220
6 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20220805_htm.xml XML 4880
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 221138584
SIC: 2834 Pharmaceutical Preparations